Passage Bio, Inc. reported a lower loss in the third quarter compared to the same period last year, surpassing Street estimates. The company’s bottom line was -$7.75 million, or -$2.44 per share, an improvement from -$19.34 million, or -$6.15 per share, in the previous year. Analysts had predicted an earnings per share of -$2.97 on average. Passage Bio, Inc.’s GAAP earnings showed a decrease in loss, with earnings at -$7.75 million compared to -$19.34 million last year, and EPS at -$2.44 versus -$6.15 last year.

Read more at Nasdaq: PASSAGE BIO, INC. Q3 Loss Decreases, Beats Estimates